102
Participants
Start Date
April 2, 2020
Primary Completion Date
December 1, 2020
Study Completion Date
January 8, 2021
Anakinra
In case of diagnosis of MAS treatment with anakinra
Tocilizumab
In case of diagnosis of immune dysregulation treatment with tocilizumab
Department of Internal Medicine, I PAMMAKARISTOS Hospital, Athens
Intensive Care Unit, General Hospital of Athens KORGIALENIO-BENAKIO E.E.S., Athens
1st Department of Pulmonary Medicine and Intensive Care Unit, Athens
Intensive Care Unit, General Hospital of Athens IPPOKRATEIO, Athens
2nd Department of Critical Care Medicine, ATTIKON University Hospital, Athens
4th Department of Internal Medicine, Attikon University Hospital, Athens
Intensive Care Unit, General Hospital ASKLEPIEIO Voulas, Athens
"Intensive Care Unit, Latsio, Thriasio Elefsis General Hospital", Elefsina
Department of Internal Medicine, Patras University Hospital, Pátrai
"Intensive Care Unit, Koutlimbaneio & Triantafylleio Larissa General Hospital", Larissa
Department of Internal Medicine, Larissa University Hospital, Larissa
Intensive Care Unit, Ioannina University Hospital, Ioannina
Department of Anesthesiology and Intensive Care Medicine, University General Hospital of Thessaloniki AHEPA, Thessaloniki
Intensive Care Unit, AGIOS DIMITRIOS General Hospital of Thessaloniki, Thessaloniki
Intensive Care Unit, G. GENNIMATAS General Hospital of Thessaloniki, Thessaloniki
Intensive Care Unit, Theageneio Oncological Hospital of Thessaloniki, Thessaloniki
Intensive Care Unit, General Hospital of Thessaloniki IPPOKRATEIO, Thessaloniki
Hellenic Institute for the Study of Sepsis
OTHER